Awj. Van 'T Hof et al., A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction, EUR HEART J, 20(9), 1999, pp. 659-665
Aims Intra-aortic balloon pumping reduces afterload and may be effective in
improving reperfusion in high risk infarct patients treated with primary a
ngioplasty.
Methods High risk infarct patients referred from other centres for primary
PTCA were randomized to treatment with or without an intra-aortic balloon p
ump. The primary end-point consisted of the combination of death, non-fatal
reinfarction, stroke or an ejection fraction <30% at the 6 month follow-up
. A weighted unsatisfactory outcome score (as previously described by Braun
wald), enzymatic infarct size and left ventricular ejection fraction were s
econdary end-points.
Results During a 3.5 year period, 238 patients were randomized, 118 to intr
a-aortic balloon pump therapy and 120 to no intra-aortic balloon pump thera
py. Cross-over (25% in the intra-aortic balloon pump group and 31% in the n
o-intra-aortic balloon pump group) occurred in both treatment arms. The pri
mary end-point was reached in 31 (26%) patients assigned to an intra-aortic
balloon pump and in 31 (26%) assigned to no intra-aortic balloon pump (P=0
.94). Enzymatic infarct size (LDHQ(72)) was calculated in 163 (68%) patient
s and was not significantly different between either group (intra-aortic ba
lloon pump: 1616 +/- 1148, no intra-aortic balloon pump: 1608 +/- 1163). Th
e left ventricular ejection fraction was measured at the 6 month follow-up
in 168 patients (80% of patients alive). No difference in ejection fraction
was found in either group (intra-aortic balloon pump: 42 +/- 13%, no intra
-aortic balloon pump: 40 +/- 14%, P=0.51). Major complications occurred in
8% of patients treated with an intra-aortic balloon pump.
Conclusion Systematic use of intra-aortic balloon pumping after primary ang
ioplasty does not lead to myocardial salvage or to a better clinical outcom
e in high-risk infarct patients. Use of intra-aortic balloon pumping after
primary PTCA for acute myocardial infarction should be reserved for patient
s with severe haemodynamic compromise.